Volume | 6,156,574 |
|
|||||
News | - | ||||||
Day High | 146.39 | Low High |
|||||
Day Low | 145.265 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | JNJ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
145.95 | 145.265 | 146.39 | 145.65 | 145.95 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
93,803 | 6,156,574 | $ 145.68 | $ 896,900,290 | - | 143.13 - 175.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:13 | 10 | $ 145.65 | USD |
Johnson and Johnson (JNJ) Options Flow Summary
Johnson and Johnson Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
350.84B | 2.41B | - | 85.16B | 35.15B | 14.59 | 9.98 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Johnson and Johnson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 147.06 | 147.27 | 143.88 | 145.82 | 5,884,814 | -1.40 | -0.95% |
1 Month | 151.61 | 154.08 | 143.71 | 146.93 | 7,305,522 | -5.95 | -3.92% |
3 Months | 155.61 | 159.14 | 143.13 | 149.14 | 7,580,226 | -9.95 | -6.39% |
6 Months | 155.21 | 163.58 | 143.13 | 154.06 | 7,236,440 | -9.55 | -6.15% |
1 Year | 164.26 | 175.97 | 143.13 | 161.51 | 11,139,074 | -18.60 | -11.32% |
3 Years | 163.48 | 186.69 | 143.13 | 165.19 | 8,493,049 | -17.82 | -10.90% |
5 Years | 140.40 | 186.69 | 109.16 | 157.79 | 8,177,388 | 5.26 | 3.75% |
Johnson and Johnson Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |